methylnaltrexone bromide 150 MG Oral Tablet [Relistor]

Verify with CMS →

methylnaltrexone bromide

RxCUI: 1801519

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
7.9%
Plan Coverage
400
Plans Covering
T4.1
Avg Tier
60.9%
Prior Auth Required

What the CMS Formulary Data Shows for methylnaltrexone bromide 150 MG Oral Tablet [Relistor]

Per the CMS 2026 Part D formulary file, methylnaltrexone bromide 150 MG Oral Tablet [Relistor] (RxNorm concept RXCUI 1801519, generic name methylnaltrexone bromide) appears on 64 distinct formulary files spanning 400 Medicare Part D plan offerings - 7.9% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.1.

Real-world access to methylnaltrexone bromide 150 MG Oral Tablet [Relistor] depends on utilization management as much as tier placement: 60.9% of covering formularies require prior authorization. 32.8% require step therapy. 71.9% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 15,141 Part D beneficiaries filled methylnaltrexone bromide 150 MG Oral Tablet [Relistor] in 2023, with total plan-and-beneficiary spending of $132,882,335 and an average per-beneficiary annual cost of $8,776.32. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry methylnaltrexone bromide 150 MG Oral Tablet [Relistor] today.

Coverage Details

Formularies covering
64
Plans covering
400
Coverage rate
7.9%
Tier range
Tier 1 – Tier 5
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
60.9% of formularies
Step therapy required
32.8% of formularies
Quantity limits
71.9% of formularies

2023 Medicare Spending

Beneficiaries
15,141
Total spending
$132,882,335
Avg per beneficiary
$8,776.32

Tier Distribution Across Plans

40 plans
Tier 1, Preferred Generic
1 plans
Tier 2, Generic
19 plans
Tier 4, Non-Preferred
40 plans
Tier 5, Specialty

Medicare Advantage Plans (MA-PD) Covering methylnaltrexone bromide 150 MG Oral Tablet [Relistor]

100 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
NaviCare (HMO D-SNP) FALLON COMMUNITY HEALTH PLAN T1 No $0 MA
Hamaspik Medicare Choice (HMO D-SNP) HAMASPIK, INC. T1 Yes $0 NY
SeniorCare Complete (HMO D-SNP) SOUTH COUNTRY HEALTH ALLIANCE T1 Yes $0 MN
AbilityCare (HMO D-SNP) SOUTH COUNTRY HEALTH ALLIANCE T1 Yes $0 MN
Alameda Alliance Wellness (HMO D-SNP) ALAMEDA ALLIANCE FOR HEALTH T1 Yes $0 CA
Provider Partners Pennsylvania Community Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF PENNSYLVANIA, INC T1 No $0 PA
Provider Partners North Carolina Community Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF NORTH CAROLINA T1 No $0 NC
Provider Partners Indiana Community Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF INDIANA T1 No $0 IN
Provider Partners Maryland Community Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN, INC. T1 No $0 MD
Provider Partners Missouri Community Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF MISSOURI, INC. T1 No $0 MO
Community Care's Partnership Program (HMO D-SNP) COMMUNITY CARE HEALTH PLAN, INC. T1 Yes $0 WI
Platino Blindao (HMO D-SNP) TRIPLE S ADVANTAGE, INC. T1 Yes $0 PR
Platino Enlace (HMO D-SNP) TRIPLE S ADVANTAGE, INC. T1 Yes $0 PR
PLATINO ADVANCE (HMO D-SNP) TRIPLE S ADVANTAGE, INC. T1 Yes $0 PR
PLATINO PLUS (HMO D-SNP) TRIPLE S ADVANTAGE, INC. T1 Yes $0 PR
Mass General Brigham SCO (HMO D-SNP) MASS GENERAL BRIGHAM HEALTH PLAN, INC T1 Yes $0 MA
Mass General Brigham One Care (HMO D-SNP) MASS GENERAL BRIGHAM HEALTH PLAN, INC T1 Yes $0 MA
Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 Yes $0 PA
Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 Yes $0 PA
Highmark Health Options Duals (HMO D-SNP) HIGHMARK HEALTH OPTIONS WEST VIRGINIA INC. T1 Yes $0 WV
Highmark Health Options Duals (HMO D-SNP) HIGHMARK BCBSD, INC. T1 Yes $0 DE
Gold Dialysis & Kidney Complete (HMO-POS C-SNP) GOLD KIDNEY OF FLORIDA INC T1 Yes $4.80 FL
Provider Partners Texas Advantage Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF TEXAS, INC. T1 No $4.80 TX
Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 Yes $13.10 PA
Provider Partners Illinois Advantage Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF ILLINOIS T1 No $15.20 IL
Gold Dialysis & Kidney Complete (HMO-POS C-SNP) GOLD KIDNEY OF ARIZONA T1 Yes $17.00 AZ
Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) GATEWAY HEALTH PLAN, INC. T1 Yes $17.60 PA
Provider Partners Maryland Advantage Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN, INC. T1 No $31.20 MD
Provider Partners Maryland Essential Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN, INC. T1 No $31.20 MD
Highmark Health Options Duals Select (HMO D-SNP) HIGHMARK BCBSD, INC. T1 Yes $31.20 DE
Provider Partners Pennsylvania Advantage Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF PENNSYLVANIA, INC T1 No $32.70 PA
Provider Partners Pennsylvania Essential Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF PENNSYLVANIA, INC T1 No $32.70 PA
Hamaspik Medicare Select (HMO D-SNP) HAMASPIK, INC. T1 Yes $34.50 NY
Provider Partners North Carolina Advantage Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF NORTH CAROLINA T1 No $36.20 NC
Provider Partners North Carolina Essential Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF NORTH CAROLINA T1 No $36.20 NC
Provider Partners Indiana Advantage Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF INDIANA T1 No $38.40 IN
Provider Partners Indiana Essential Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF INDIANA T1 No $38.40 IN
Provider Partners Kentucky Advantage Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF KENTUCKY T1 No $38.40 KY
Provider Partners Missouri Advantage Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF MISSOURI, INC. T1 No $43.00 MO
Provider Partners Missouri Essential Plan (HMO I-SNP) PROVIDER PARTNERS HEALTH PLAN OF MISSOURI, INC. T1 No $43.00 MO
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T2 Yes $0 CA
Troy Medicare (HMO) TROY HEALTH, INC. T4 Yes $0 NC
Troy Medicare for Dual-eligible Beneficiaries (HMO D-SNP) TROY HEALTH, INC. T4 Yes $0 NC
Contra Costa Health Care Plus (HMO D-SNP) CONTRA COSTA COUNTY MEDICAL SERVICE DBA CONTRA COSTA HEALTH T4 Yes $0 CA
Keystone First VIP Choice (HMO D-SNP) VISTA HEALTH PLAN, INC. T4 Yes $0 PA
AmeriHealth Caritas VIP Care (HMO D-SNP) VISTA HEALTH PLAN, INC. T4 Yes $0 PA
First Choice VIP Care (HMO D-SNP) SELECT HEALTH OF SOUTH CAROLINA, INC. T4 Yes $0 SC
AmeriHealth Caritas VIP Care (HMO D-SNP) AmeriHealth Caritas VIP Next, Inc. T4 Yes $0 DE
AmeriHealth Caritas VIP Care Choice (HMO D-SNP) AmeriHealth Caritas VIP Next, Inc. T4 Yes $0 DE
AmeriHealth Caritas VIP Care (HMO D-SNP) AMERIHEALTH CARITAS FLORIDA INC T4 Yes $0 FL

Frequently Asked Questions

Is methylnaltrexone bromide 150 MG Oral Tablet [Relistor] covered by Medicare Part D?

Yes, methylnaltrexone bromide 150 MG Oral Tablet [Relistor] is covered by 400 Medicare Part D plans (7.9% of all Part D formularies).

What tier is methylnaltrexone bromide 150 MG Oral Tablet [Relistor] on Medicare Part D plans?

methylnaltrexone bromide 150 MG Oral Tablet [Relistor] averages Tier 4.1 across Part D plans, ranging from Tier 1 to Tier 5.

Does methylnaltrexone bromide 150 MG Oral Tablet [Relistor] require prior authorization?

60.9% of Part D formularies require prior authorization for methylnaltrexone bromide 150 MG Oral Tablet [Relistor]. Step therapy: 32.8%. Quantity limits: 71.9%.

How much does Medicare spend on methylnaltrexone bromide 150 MG Oral Tablet [Relistor]?

In 2023, total Medicare Part D spending on methylnaltrexone bromide 150 MG Oral Tablet [Relistor] was $132,882,335, covering 15,141 beneficiaries. The average spend per beneficiary was $8,776.32.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial